Nasdaq

Biocept's Target Selector™ Liquid Biopsy Demonstrated High Accuracy When Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins ...

Using Target Selector™ to detect HER2 alterations assists physicians in reassessing therapy options over the course of treating patients with metastatic breast cancer SAN DIEGO, Dec. 10, 2020 ...
Nasdaq

Biocept Announces CE-IVD Mark and Availability of its Target Selector™ EGFR Molecular Assay Kit in Europe

Target Selector™ assay kits enable assay developers to leverage Biocept's patented, high-sensitivity technology for the detection of key actional oncogene mutations from both tissue biopsies and blood ...
Business Wire

Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will present data showing that its Target Selector™ molecular assay ...
Business Wire

Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector™ Assay Kit for Non-Small Cell Lung Cancer Patients

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will collaborate with Protean BioDiagnostics Inc. to research the ...
Pharmabiz

Quest Diagnostics offers Biocept's liquid biopsy-based Target Selector NGS Lung Panel test

Quest Diagnostics, a leading provider of diagnostic information services, announced that physicians in the United States can now order the liquid biopsy-based Target Selector NGS Lung Panel test ...
Proactiveinvestors

Biocept expanding uses for its Target Selector liquid biopsy technology to detect cancer biomarkers

Small Cap watch: Lindian's new CFO, Far East Gold retains 51% Woyla interest; 'Spectacular' drill results for St George ...